General
Preferred name
Triheptanoin
Synonyms
IND-106011 ()
UX-007 ()
IND106011 ()
UX007 ()
IND 106011 ()
UX 007 ()
1,2,3-Triheptanoyl-rac-glycerol ()
triheptanoin, Ultragenyx ()
IND106011, UX007, Glycerol trienanthate ()
Dermofeel tc 7 ()
Dub thg ()
Lanol 37 t ()
Trioenanthoin ()
Dojolvi ()
Radiamuls 2375 ()
Heptanoin, tri- ()
Dermofeel tc-7 ()
Triheptanoic glyceride ()
Trienanthoin ()
1,2,3-Triheptanoyl Glycerol ()
P&D ID
PD059029
CAS
620-67-7
Tags
available
drug
Approved by
FDA
First approval
2020
Drug Status
investigational
approved
Max Phase
Phase 4
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Triheptanoin is a medium-chain triglyceride that is administered as a rescue therapeutic in patients with long-chain fatty acid oxidation disorders . (GtoPdb)
Compound Sets
13
Cayman Chemical Bioactives
28174
ChEMBL Approved Drugs
CHEMBL4297585
ChEMBL Drugs
CHEMBL4297585
DrugBank
DB11677
DrugBank Approved Drugs
DB11677
DrugCentral
5399
DrugCentral Approved Drugs
5399
Guide to Pharmacology
11431
MedChem Express Bioactive Compound Library
HY-W013136
NCATS Inxight Approved Drugs
2P6O7CFW5K
ReFrame library
Selleckchem Bioactive Compound Library
triheptanoin
TargetMol Bioactive Compound Library
T19663
External IDs
27
Properties
(calculated by RDKit )
Molecular Weight
428.31
Hydrogen Bond Acceptors
6
Hydrogen Bond Donors
0
Rotatable Bonds
20
Ring Count
0
Aromatic Ring Count
0
cLogP
5.9
TPSA
78.9
Fraction CSP3
0.88
Chiral centers
0.0
Largest ring
0.0
QED
0.14
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
fatty acid metabolic
Source data